Stryker Corporation (SYK) Stock
Healthcare · Medical Devices · Member of S&P 500
Stryker Corporation (SYK) closed at USD 281.62 on 2026-10-14, a change of -24.3 % over the past year, with a market capitalization of USD 112.48B.
Stryker Corporation recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 281.62 |
| 2026-10-13 | 282.55 |
| 2026-10-12 | 282.60 |
| 2026-10-09 | 277.33 |
| 2026-10-08 | 276.97 |
| 2026-10-07 | 275.40 |
| 2026-10-06 | 278.20 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Stryker Corporation key figures
- Previous close
- USD 281.62 (2026-10-14)
- 1-year change
- -24.3 %
- Market cap
- USD 112.48B
- Enterprise value
- USD 124.45B
- P/E ratio (trailing)
- 29.29
- P/E ratio (forward)
- 17.58
- EPS (trailing)
- 10.01
- EPS (forward)
- 16.68
- PEG ratio
- 1.32
- Price to book
- 4.69
- Revenue growth
- 9.4 %
- Earnings growth
- 44.1 %
- Dividend per share (trailing)
- 3.48
- Short ratio
- 1.85
- Employees
- 56,000
- Analyst consensus (third-party)
- buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Stryker Corporation and compare it with other stocks.
Analyze SYKAll S&P 500 stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Stryker Corporation shares.